Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. With its Immune Repertoire Capture™ (IRC™) technology, Atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. Atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. Atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health. If you are interested in becoming part of the Atreca team, our open positions can be found at: http://www.atreca.com/careers/
View Top Employees from Atreca, Inc.Website | http://www.atreca.com/ |
Ticker | BCEL |
Revenue | $25.7 million |
Funding | $341 million |
Employees | 105 (105 on RocketReach) |
Founded | 2011 |
Phone | (650) 595-2595 |
Fax | (650) 453-2410 |
Technologies |
JavaScript,
HTML,
PHP
+33 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Health Care, Therapeutics |
Web Rank | 2 Million |
Keywords | Atreca, Atreca Inc, Biotech Companies In Bay Area, Atreca Careers, Travis Kalanick |
Competitors | Allakos Inc, Forma Therapeutics, Magenta Therapeutics, Protagonist Therapeutics, Visterra Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Atreca, Inc. employee's phone or email?
The Atreca, Inc. annual revenue was $25.7 million in 2024.
Tito Serafini is the Chief Strategy Officer, Director, and Founder of Atreca, Inc..
105 people are employed at Atreca, Inc..
Atreca, Inc. is based in South San Francisco, California.
The NAICS codes for Atreca, Inc. are [541711, 541, 5417, 54, 54171].
The SIC codes for Atreca, Inc. are [87, 873].